biOasis Announces Oversubscription of Financing
31 mars 2017 18h06 HE
|
biOasis Technologies Inc.
VANCOUVER, BC--(Marketwired - March 31, 2017) - NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESBIOASIS TECHNOLOGIES INC. (OTCQB: BIOAF) (TSX VENTURE:...
biOasis Provides AGM Update -- Expanding The biOasis Deal Flow Pipeline
22 janv. 2017 21h30 HE
|
biOasis Technologies Inc.
VANCOUVER, BC--(Marketwired - January 22, 2017) - BIOASIS TECHNOLOGIES INC. (OTCQB: BIOAF) (TSX VENTURE: BTI), a pioneering biopharmaceutical company focused on the delivery of therapeutic drugs...
biOasis Attends BIO Europe and the Lockman BT2111 Paper is Honored by being Featured on the Cover of Pharmaceutical Research's December Journal
06 nov. 2016 22h00 HE
|
biOasis Technologies Inc.
VANCOUVER, BC--(Marketwired - November 06, 2016) - BIOASIS TECHNOLOGIES INC. (OTCQB: BIOAF) (TSX VENTURE: BTI), a pioneering biopharmaceutical company focused on overcoming the limitations of...
biOasis Engages Rising Tide Equity to Increase Global Awareness
23 oct. 2016 19h55 HE
|
biOasis Technologies Inc.
VANCOUVER, BC--(Marketwired - October 23, 2016) - BIOASIS TECHNOLOGIES INC. (OTCQB: BIOAF) (TSX VENTURE: BTI), a pioneering biopharmaceutical company focused on overcoming the limitations of...
biOasis Enters Into a License Agreement With Vaccinex Inc.
20 sept. 2016 20h00 HE
|
biOasis Technologies Inc.
VANCOUVER, BC--(Marketwired - September 20, 2016) - BIOASIS TECHNOLOGIES INC. (OTCQB: BIOAF) (TSX VENTURE: BTI) ("biOasis"), a pioneering biopharmaceutical company focused on overcoming the...
biOasis Announces Publication of Scientific Paper -- Transcend-Based Anti-Cancer Antibody BT2111 Crosses the Blood-Brain Barrier and Shows Efficacy in the Treatment of Metastatic HER2+ Breast Cancer Tumors in the Brains of Animal Model
29 août 2016 17h47 HE
|
biOasis Technologies Inc.
VANCOUVER, BC--(Marketwired - August 29, 2016) - BIOASIS TECHNOLOGIES INC. (OTCQB: BIOAF) (TSX VENTURE: BTI), a pioneering biopharmaceutical company focused on overcoming the limitations of...
biOasis Announces the Issuance of an Additional US Patent for the Delivery of Therapeutic Agents Across the Blood-Brain Barrier
10 juil. 2016 20h53 HE
|
biOasis Technologies Inc.
VANCOUVER, BC--(Marketwired - July 10, 2016) - biOasis Technologies Inc. (OTCQB: BIOAF) (TSX VENTURE: BTI), a pioneering biopharmaceutical company focused on overcoming the limitations of...
biOasis Technologies Inc. to Present at BIO International Conference in San Francisco on June 7, 2016
17 mai 2016 18h07 HE
|
biOasis Technologies Inc.
VANCOUVER, BC--(Marketwired - May 17, 2016) -
BIOASIS TECHNOLOGIES INC. (OTCQB: BIOAF) (TSX VENTURE: BTI), a pioneering biopharmaceutical company focused on overcoming the limitations of...
biOasis Technologies Enters Into a License Agreement With Astellas Research Institute of America LLC
21 avr. 2016 18h28 HE
|
biOasis Technologies Inc.
VANCOUVER, BC--(Marketwired - April 21, 2016) - biOasis Technologies Inc. (TSX VENTURE: BTI) (OTCQB: BIOAF) (the "Company") announces that it has entered into a License Agreement to collaborate...
biOasis to Present at the Brains for Brain 10th Annual Workshop and Open Conference in Madrid, Spain
17 mars 2016 23h36 HE
|
biOasis Technologies Inc.
VANCOUVER, BC--(Marketwired - March 17, 2016) - biOasis Technologies Inc. (TSX VENTURE: BTI) (OTCQB: BIOAF) (the "Company") on Saturday, March 19, 2016 at 11:45am, will present the data from the...